Growth for health and pharma, built for regulated markets.
Independent · AI-native · ISO 9001 + ISO 27001
Health and pharma are two different growth problems under one hard constraint: the most regulated, most trust-gated corner of marketing, where discovery now runs across search, referrals, local and, increasingly, AI answers. Wise Pirates helps health brands fill the funnel and pharma brands earn trust, with the process and data rigor these markets demand.
What we do for health and pharma, in one minute.
The rest of this page goes deep. If you read only one part, read this: we run two playbooks under one certified engine, so health brands fill the funnel, pharma brands earn trust, and both get found and cited in the AI answer, measured to real results.
More of the right patients
Lead generation, qualification, booking and experience for clinics, hospital groups, medtech, digital health and insurers, on consented first-party data.
Brand and HCP trust, compliantly
Branding, MLR-aware content, HCP engagement, patient support and disease-awareness that respects every rule, from the DTC ban to pharmacovigilance.
Get found, get cited, prove it
Full-funnel discovery across search, local and AI answers, so you are more likely to be cited, plus honest measurement and ISO-grade data and process across both.
In one line: two playbooks, one certified growth engine, for the sector where the rules are strict and trust decides who gets chosen.
Two submarkets, many kinds of brand.
Across health and pharma the growth problems rhyme, but the specifics differ. We adapt the playbook to your submarket and your rules.
Providers & hospital groups
Clinics, hospital groups, dental, aesthetics and fertility, growing patient demand for high-value service lines.
Insurers, medtech & digital health
Health insurers and payers, device makers, telehealth and digital health, where lead generation meets regulated care.
Pharma & biotech brands
Prescription and OTC brands, biotech and medical affairs, marketed under MLR review and the EU advertising rules.
Consumer & animal health
Consumer health, wellness and animal health, where public advertising is allowed but still rule-bound.
Medtech and digital health straddle both: they need pharma-grade regulatory care and health-grade lead generation at once. That is exactly the bridge we are built to run.
Deep in health and pharma, and built for regulated markets.
We have grown more than thirty companies across health and pharma, with real depth on both sides: patient demand for providers and payers, and brand and HCP work for pharma under review. Two related submarkets, each with its own rules, its own buyer and its own definition of a win.
We also work where the rules are hardest. Pharma answers to Infarmed and the EMA; finance, another sector we serve, answers to the Banco de Portugal and the ECB, scrutiny that rivals pharma’s. Being certified to ISO 9001 for quality and ISO 27001 for information security is proof of the planning, process and data discipline that these sectors demand.
Regulated by design
We have built and shipped in Infarmed and EMA-grade pharma environments and Banco de Portugal and ECB-grade finance environments. Compliance and data trust are not a brake on our growth work. They are why it ships and scales.
Independent and AI-native
We are not a pharma-only network priced for the giants, and not a lead-gen mill that ignores the rules. We are the independent, AI-native partner that treats health and pharma as two deliberate playbooks.
The mid-market is the market. The enterprise networks are built for the largest companies and default to the US. We built Wise Pirates to give mid-market health and pharma brands the senior firepower and proprietary technology usually reserved for the giants.
The patient and the doctor went digital. AI is changing how they search.
Patients now start with a search, a review or an AI chatbot rather than only a referral, and doctors research the same way. Pharma marketing has moved overwhelmingly online. The channels still matter together, search, local, referral and now AI answers, but the mix is shifting, and the rules on what you can say have never been tighter.
global pharmaceutical market in 2025, on the way to around $2.3 trillion by 2029.IQVIA, 2025
people ask an AI a health question every single day, a new front door to care.OpenAI via Healthcare Dive, 2026
bans advertising prescription medicines to the public. Only the US and New Zealand allow it.Directive 2001/83/EC
of prescriptions in Portugal are already issued digitally, one of Europe’s most digital health systems.ePrescription, INFARMED
Four forces are squeezing health and pharma growth at once.
None of these is going away, and generic agencies tend to trip on all four. We built the practice around them.
Discovery is spreading into the AI answer
More patients and doctors now get part of their answer before any website is clicked. AI joins search, local and referral as a place you need to show up, and being among the cited sources is becoming part of the game.
Trust is judged harder than anywhere
Health is the strictest quality category online. Authority, expertise and reputation, not keyword tricks, decide who gets surfaced and who gets ignored.
Compliance shapes everything you say
MLR review, the EU ban on prescription advertising, HCP codes and pharmacovigilance mean the message is a compliance discipline first, a creative one second.
Your data is the most protected there is
Health data is special-category under GDPR. You cannot retarget it like an e-commerce list, so growth has to be built on explicit consent and certified handling.
Health fills the funnel. Pharma earns trust. One engine runs both.
This is the heart of how we work. Health growth is a demand problem: find, qualify, book, care for and keep patients. Pharma growth is a trust problem: build evidence, engage HCPs, stay compliant, educate and become the source that gets cited. Different motions, one shared spine of AI discovery, measurement and certified data.
Fill the funnel
For clinics, hospital groups, medtech, digital health and insurers, where the job is to acquire and keep the right patients and members.
- Patient lead generation for high-value service lines
- Lead qualification and speed-to-lead routing across sites
- Booking and conversion-rate optimization
- No-show reduction, reputation and reviews
- Local and multi-location SEO, plus AI-referral visibility
- Consented first-party patient data, CRM, retention and recall
Earn trust
For prescription, OTC, biotech, consumer and animal health brands, where the job is to build trust and move behaviour under review.
- Brand building and scientific, evidence-anchored content
- Content that reaches review already review-ready
- HCP omnichannel engagement and segmentation
- Patient support programs and adherence
- Unbranded disease-awareness, the compliant route to the public
- GEO and AI citation for conditions, within the rules
Same firm, two deliberate playbooks. The underlying work is the same: getting found and cited in AI answers, measuring what actually worked, and handling health data to a certified standard.
Turn a search or an AI question into a booked patient.
Health is a local, high-intent, high-anxiety category. The winners are found fast, qualify well, make booking effortless, keep the promise and bring patients back. Every step is measurable, and some of it is hard-dollar.
Lead generation and qualification
Paid and organic capture for the service lines that matter, then AI qualification and speed-to-lead routing to the right clinic and specialty.
Booking, CRO and no-show reduction
Frictionless scheduling, reminders, online check-in and prepay, so interest becomes a kept appointment, not a gap in the calendar.
Reputation, social and AI referral
Reviews, local and multi-location presence, an active social presence for awareness, reputation and social proof, and the authority signals that improve the chance of the clinic being cited by AI assistants.
And it compounds: consented first-party patient data feeds CRM, recall and retention, so the next visit does not need to be bought again.
Build the brand and the HCP relationship, under review.
Pharma marketing is a trust and compliance discipline. In the EU you often cannot speak to the patient about a prescription medicine at all, so growth runs through HCP engagement, evidence, patient support and unbranded disease awareness. The bottleneck is rarely ideas. It is getting compliant content through review at the speed the market moves.
HCP omnichannel that respects the code
Segmented, multichannel engagement for digital-first and rep-dependent HCPs, with every transfer of value documented and disclosed as the EFPIA code requires.
Content that reaches review review-ready
We pre-check claims, link them to approved references and flag gaps before human review, so medical, legal and regulatory sign-off is faster without losing the audit trail.
Disease awareness, a compliant route to public education
Genuinely unbranded education about a condition, with no direct or indirect product reference, can be a compliant way to educate the public when it meets the applicable requirements, and one of the ways a brand becomes a source an AI cites.
Patient support and adherence
Onboarding, education and adherence programs that improve outcomes and the brand relationship, with pharmacovigilance capture built into every channel.
The KPIs we move here: HCP engagement, content approval time, brand consideration, patient-support enrolment and adherence, so the impact on the business is as clear as it is on the health side.
Social media runs through both playbooks: in health for awareness, reputation, social proof and lead generation; in pharma for compliant content, disease awareness, social listening and HCP or corporate communication when applicable.
Consumer health, OTC and animal health are different again: public advertising is allowed, so the work is closer to normal consumer marketing, but still rule-bound. We flex the playbook to what each product may say.
When someone asks an AI who to trust, are you the answer?
A patient describes symptoms to ChatGPT. A doctor asks about a therapy area. The AI reads a handful of sources and returns one answer. Page-one ranking still matters, but it is no longer the whole story when many of these searches end with no click. Being among the sources cited inside the answer is becoming one more place to show up, alongside search, local and referral, and in health and pharma that citation has to be earned within the rules.
A corroborated entity
Who you are, confirmed in the knowledge graphs and structured data the models read, so an AI can trust and name you.
Citable, compliant content
Authoritative, evidence-anchored answers the models want to quote, engineered to stay within health and pharma rules.
Ecosystem presence
Reviews, references and mentions on the sources an AI draws from, so your brand is in the answer, not just on your own site.
This is our Wise GEO Compass framework applied to health and pharma: we engineer the citable content, the entity and the ecosystem presence that improve your chances of being named by an AI, and we measure your share of the answer against competitors, every month. It is one more way to reach the patient and the doctor, alongside search, local and referral.
In regulated markets, rigor is how you move faster.
Most agencies treat compliance as a tax that slows growth down. We treat it as the operating system that lets growth ship at all. The clearest example is pharma content review: the ideas are rarely the bottleneck, the routing, versioning and reference-linking are. AI-native, auditable content operations cut that timeline sharply, without losing accountability.
We build to your codes, and your medical, legal and regulatory reviewers stay the final word. We make their job faster, not optional. The proof is not a slogan, it is our certification and our track record. ISO 9001 for quality and process, ISO 27001 for information security, and real work delivered in pharma and finance, two of the most regulated sectors there are.
The health and pharma growth engine, part by part.
Everything connects to one outcome: patients and trust you can measure. We start where the return is fastest and build the rest around it.
Demand that respects the rules
Search, social and programmatic tuned to health intent and HCP audiences, with claims and targeting kept compliant.
Be the answer AI gives
Generative and answer engine optimization so you are cited in ChatGPT, Perplexity and AI Overviews, within health and pharma guardrails.
Authority the models trust
Evidence-anchored, YMYL-grade content and technical SEO that earns the authority health search now demands.
From interest to booked
Booking flows, site experience and conversion optimization that turn demand into kept appointments and members.
Consented, and yours
Patient and customer data built on explicit consent, on your own stack, powering retention, recall and lookalikes.
Proof the CFO trusts
Marketing mix modeling and incrementality on your own data, so you know what actually moved patients and scripts.
Trust you can see
Brand, scientific and disease-awareness creative that reads as credible to patients, doctors and reviewers alike.
Omnichannel, MLR-aware
HCP engagement and content operations that clear review faster and keep the audit trail intact.
Enterprise firepower, sized for mid-market health and pharma.
The global networks are built for the largest pharma companies and the biggest hospital systems, with enterprise price tags and US-first defaults. We are built for mid-market providers, insurers, medtech and mid-sized pharma and consumer-health brands that need results this year, with the senior team and proprietary technology usually reserved for the giants.
Run it, ride beside you, or advise
Engagements sized to your scale and budget, with no holdco overhead. You pay for what moves the needle, not for layers.
The crew, not a training ground
You work with senior people who already understand health, pharma and their rules, backed by our proprietary frameworks.
Prove it in the first quarter
We start where the return is fastest, AI visibility, a lead engine or the measurement foundation, and show a result before asking for more.
Mid-market health and pharma brands are underserved by agencies built for the enterprise. We were built for them, on purpose. We work on mid to long term strategy, without ignoring the need for short term results.
Growth also needs automation, security and people ready for it.
In regulated health and pharma, marketing does not win alone. The same senior team brings the operational and technology layers that make growth stick, and that most agencies do not touch.
A lean team that ships like a big one
We automate the repetitive across marketing, medical and back-office operations, and put governed agents to work, so a small team does far more.
Trust is non-negotiable here
Patient data, HCP systems and connected devices are targets. We secure the agents and the data, with security built in and our ISO 27001 discipline behind it.
The capability stays in your team
The biggest blocker is skills. We get your people using data, AI and the tools safely and fast, so the know-how stays in-house, not rented.
These run on our Process Automation & Agentic AI, Agentic Security and AI Enablement practices, alongside Wise BI Foundry for the data foundation. One partner for the growth engine and the compliant backbone under it.
Where our health and pharma approach is different.
The market usually offers two strengths in different places: health and pharma networks are strong on regulation, brand and HCP relationships; the usual performance and media agencies are strong on acquisition and media. We bring growth, data and execution together, with processes ready for regulated markets, for both submarkets.
| Capability | Health & pharma networks | Performance & media agencies | Wise Pirates |
|---|---|---|---|
| Regulated pharma creative & HCP engagement | Strong | Rare | Yes, MLR-aware |
| Performance lead generation for providers | Rare | Strong | Yes, on consented data |
| GEO / AI-answer visibility for health & pharma | Enterprise only | Not built for the rules | Owned, with a proprietary framework |
| Proprietary Meta performance tool | None | Off-the-shelf platforms | Owned, only we have it |
| Health and pharma as two deliberate playbooks | Pharma-led | One industry among many | Owned |
| Certified data & process rigor (ISO 9001 + 27001) | Varies | Rare | Built in |
| All of it, as one accountable partner | Enterprise scale, US-first | Point solutions | Service + proprietary tech, results-first |
The networks lead on regulation, brand and HCP relationships; the usual agencies lead on acquisition and media. We bring growth, data and execution together, with processes ready for regulated markets, and answer for the result. One partner for demand and trust, AI-era discovery, consented data and certified process.
What the data is saying.
The shift is documented. We build for it.
The most protected data there is
Health data is special-category, prohibited to process by default and allowed only with explicit consent. Casual retargeting is not an option here, certified handling is.
The rules do not stop at the ad
Every transfer of value to a doctor must be documented and disclosed, and digital counts as public communication. Compliance shapes the whole engagement, not just the message.
The digital front door keeps widening
The telemedicine market is growing around 11% a year, toward roughly $252 billion by 2030. More care starts online every year, in search and in AI.
Independent, published figures, not ours. Every one was checked before publication.
What it looks like when it works.
Two anonymized results we can show, one on the health side and one on the pharma side. Client identities and fuller figures are shared under engagement.
Cheaper acquisition, better leads, less risk
more efficient
on paid search
channel (Meta)
- Diversified demand off a single platform, cutting reliance on one channel from 84% to 48% and de-risking the whole funnel.
- Lifted paid-search quality score by 17% with better intent, landing pages and account structure, which compounds into lower cost.
- Drove cost per acquisition down 22% while holding volume, measured to booked appointments in the CRM on consented data.
The point: more efficient acquisition and a funnel that no longer depends on one platform, proven over twelve months.
Micro-local performance that grew a leading brand
already strong brand
awareness
score
- Geo-referenced, micro-local activation: asymmetric branding and content delivery mapped to catchment-level audiences, fed by near real-time market-share data.
- Identified the highest-opportunity audiences and ran a DCO program with large-scale A/B experimentation against them, letting data pick the winning message per audience.
- Held the lead with constant, data-driven actions that mitigated and out-positioned challenger brands, alongside reputation management that lifted the reputation score.
The point: 14% more share on an already strong brand, won micro-locally and defended against challengers, with data driving every action.
Both are from real engagements, shown anonymized, and both run on the same principle: use data to drive every action, and measure to a result on the client's own terms. Client identities and fuller figures are shared under engagement.
A partner with the range this needs.
Clients rate us on it: in our latest client survey, satisfaction ran 94% good or excellent on readiness and responsiveness, with an NPS above 60. Bold, independent and transparent: no holdco markup games, no black boxes, and a team not afraid to have an opinion. All we do comes down to one thing, your business results, and we bring the best of people, frameworks and proprietary technology to it.
Because growth here lives where marketing meets the rules.
We run both playbooks
Fill the funnel for providers and payers, earn trust for pharma brands, one accountable partner rather than two.
We are built for the rules
Compliant content operations, consented data and certified process, so growth ships without putting the brand at risk.
We bring proprietary tech
Wise GEO Compass, BI Foundry, MMM, Sidecar, Wise Horizon and our proprietary Meta performance tool give an edge in the emerging, AI-era areas where discovery is shifting.
The tools change; the team, the frameworks and the accumulated data stay. That is the partner a regulated health or pharma brand needs for the next decade.
200+ health and pharma cases, across 12 countries.
We are an independent agency and a member of ICOM, an international network of independent agencies. Through it we can draw on more than 200 health and pharma cases across 12 countries: shared benchmarks and playbooks, specialist partners, and local-market and regulatory knowledge on the ground. A mid-market brand gets global pattern recognition and international reach, with one accountable partner and no holding-company overhead.
What works, proven elsewhere first
We bring pattern recognition from health and pharma work across markets, so your plan starts from what already worked, not from a blank page.
On-the-ground market knowledge
Partners who know the local rules, media and language, useful when a brand expands or runs a campaign across several countries at once.
Network reach, boutique accountability
You get the reach of a network and a single senior team that owns your result, without the layers and markups of a holding company.
The network extends the reach. The accountability stays with one team: ours.
The frameworks that power your health and pharma growth.
The health and pharma playbooks run on the rest of what we do, so presence turns into patients and trust, and both turn into measured results, with one partner.
Every clinic and lab runs on email, docs and collaboration.
Beyond growth, every health and pharma organization needs a solid partner for email and the docs, sheets and slides suite its people live in. We are a Google Workspace reseller for the fastest-growing productivity suite in the world, at competitive prices, with Gemini AI built in, and set up for organizations that care about security and control.
One partner, better pricing
Consolidated billing in euros, competitive pricing, migration and real support, so the productivity backbone is one less thing to worry about.
AI where your team already works
Gemini across Gmail, Docs, Sheets and Meet, so a lean team drafts, summarises and analyses faster, with admin control.
Security and admin that fit
Granular access, device and data controls that suit organizations handling sensitive information. Scales seat by seat.
The same partner for your growth engine and your everyday tools. See our Google Workspace offer →
Built in the language of the industry.
Depth here is not only strategy, it is vocabulary. We operate inside the terms your commercial, medical and market-access teams use every day, and that fluency is how credibility and adjacency engagement build with professional and HCP-facing audiences.
Segmentation, targeting, orchestration, evidence and measurement, in the language your teams already speak, applied to growth on both the health and the pharma side.
Health and pharma, answered.
What does Wise Pirates do for health and pharma companies?
How is health different from pharma, and why one partner?
Can you work inside pharma regulation like Infarmed, EMA and the EU rules?
Why does AI search and GEO matter so much in health and pharma?
How do you handle patient and health data safely?
We are a mid-market clinic group or pharma brand. Are we too small for you?
What health and pharma sub-sectors do you serve?
Do you guarantee we get mentioned by ChatGPT, Gemini or Perplexity?
Where do the numbers on this page come from?
Grow in the sector where trust is everything.
Whether you are filling the funnel for a health brand or earning trust for a pharma brand, let's talk. Tell us your submarket and where you want to grow, and our senior team will walk you through how we would get you found, get you cited and prove the result, within the rules.
Book a conversation with our team →
